Insider Transactions in Q1 2025 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,288
-6.59%
|
$1,365,552
$54.0 P/Share
|
|
Feb 19
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,947
-2.53%
|
$101,244
$52.8 P/Share
|
|
Feb 19
2025
|
Julianne Bruno Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
333
-4.5%
|
$17,316
$52.8 P/Share
|
|
Feb 18
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+4.74%
|
-
|
|
Feb 18
2025
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
9,595
-11.62%
|
$508,535
$53.85 P/Share
|
|
Feb 18
2025
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,640
-5.58%
|
$640,200
$55.05 P/Share
|
|
Feb 18
2025
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,250
+5.97%
|
-
|
|
Feb 18
2025
|
Julianne Bruno Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+8.08%
|
-
|
|
Feb 16
2025
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+19.49%
|
-
|